GLOW: The GHK-Cu + TB-500 + BPC-157 Blend
Why three skin- and tissue-research peptides are studied together in one vial, and what KLOW adds on top.
Three peptides, complementary mechanisms
GLOW is a pre-blended research vial combining GHK-Cu, TB-500, and BPC-157, three well-studied skin- and tissue-research peptides, each acting through a different pathway.
GHK-Cu
A naturally occurring copper tripeptide studied in skin-remodeling, wound-healing, and regeneration research, the component most associated with the "glow."
TB-500
A synthetic fragment of Thymosin Beta-4 (Tβ4), a 43-amino-acid actin-binding protein. In preclinical research it's studied for actin regulation, cell migration, angiogenesis, and a more systemic distribution.
BPC-157
A gastric pentadecapeptide studied in tissue-repair models for local healing and angiogenesis.
Why blend them, and what KLOW adds
The research rationale is complementary coverage in a single vial: GHK-Cu's skin/regeneration signal, TB-500's systemic cell-migration reach, and BPC-157's local repair. KLOW is the same blend plus KPV, a tripeptide studied for its anti-inflammatory profile.
Research status
Both are preclinical research compounds, not approved drugs. For laboratory research use only. Not for human consumption.